Related Experiment Video
Updated: Aug 6, 2026

Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells
Published on: October 6, 2010
Biofilm and blaOXA-40 Co-Production: A Key Pathogenic Strategy in Hospital-Adapted Pseudomonas aeruginosa
Hossein Ghahremanpour1, Amin Talebi Bezmin Abadi1, Abbas Ali Imani Fooladi2
1Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Background:
The coexistence of both carbapenem resistance and biofilm formation in Pseudomonas aeruginosa represents a major clinical challenge, particularly in intensive care units (ICUs). This study investigated antimicrobial resistance, carbapenemase genes, and biofilm-related characteristics in ICU and non-ICU isolates.
Methods:
A total of 130 non-duplicate P. aeruginosa clinical isolates were collected from hospitalized patients. Antimicrobial susceptibility testing was performed using the disk diffusion method. Carbapenemase production was assessed using mCIM/eCIM assays. Biofilm formation was quantified using a microtiter plate assay. Carbapenemase genes (blaKPC-2, blaOXA-40, blaOXA-48, blaGES-2, blaVIM, blaIMP, and blaNDM-1) and biofilm-associated genes (algD, pelF, and pslD) were detected by PCR, while algD and pelF expression levels were evaluated by qPCR.
Results:
Resistance to meropenem (61.5%) and imipenem (60%) was significantly higher among ICU isolates. Carbapenemase production was detected in 91% of carbapenem-resistant isolates. The blaGES-2 gene was the predominant carbapenemase determinant (93.6%), followed by blaNDM-1 (14.6%). This study reports the first sequenced P. aeruginosa isolates harboring blaOXA-40 in Iran. Carbapenem-resistant isolates demonstrated significantly stronger biofilm formation and higher algD and pelF expression compared with carbapenem-susceptible isolates (p <0.01). ICU hospitalization, male sex, and tracheal aspirates were identified as independent risk factors for acquiring carbapenem-resistant P. aeruginosa.
Conclusion:
The high prevalence of extensively drug-resistant, carbapenem-resistant P. aeruginosa isolates in ICUs, together with enhanced biofilm formation and carbapenemase production, highlights an important therapeutic and infection control challenge. Continuous surveillance and molecular monitoring are essential for the effective management of hospital-associated infections.
Insights
Carbapenem-resistant Pseudomonas aeruginosa, common in ICUs, shows increased biofilm formation. This highlights a significant challenge for infection control and treatment, necessitating ongoing surveillance.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Molecular Biology
Background:
- Pseudomonas aeruginosa's carbapenem resistance and biofilm formation pose clinical challenges, especially in intensive care units (ICUs).
- This study examined antimicrobial resistance, carbapenemase genes, and biofilm characteristics in ICU and non-ICU P. aeruginosa isolates.
Purpose of the Study:
- To investigate antimicrobial resistance patterns, carbapenemase gene prevalence, and biofilm formation in Pseudomonas aeruginosa.
- To identify risk factors associated with carbapenem-resistant P. aeruginosa in hospitalized patients.
Main Methods:
- Analyzed 130 P. aeruginosa isolates using disk diffusion for antimicrobial susceptibility.
- Assessed carbapenemase production via mCIM/eCIM assays and quantified biofilm formation using microtiter plates.
- Detected carbapenemase and biofilm-associated genes (blaKPC-2, blaOXA-40, blaOXA-48, blaGES-2, blaVIM, blaIMP, blaNDM-1, algD, pelF, pslD) by PCR and gene expression by qPCR.
Main Results:
- ICU isolates showed significantly higher resistance to meropenem (61.5%) and imipenem (60%).
- blaGES-2 (93.6%) and blaNDM-1 (14.6%) were the predominant carbapenemase genes; blaOXA-40 was newly identified in Iran.
- Carbapenem-resistant isolates exhibited stronger biofilm formation and higher algD/pelF expression (p <0.01), with ICU stay, male sex, and tracheal aspirates as risk factors.
Conclusions:
- High prevalence of extensively drug-resistant P. aeruginosa in ICUs, coupled with enhanced biofilm formation, presents a major therapeutic and infection control problem.
- Continuous surveillance and molecular monitoring are crucial for managing hospital-associated infections caused by these resistant strains.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Colonisation of Pathogens

